2-(2,5-diketo-1,3-dimethyl-imidazolidin-4-yl)acetic acid
(1,3-Dimethyl-2,5-dioxoimidazolidin-4-yl)-acetic acid
CAS: 26972-48-5
Molecular Formula: C7H10N2O4
2-(2,5-diketo-1,3-dimethyl-imidazolidin-4-yl)acetic acid - Names and Identifiers
2-(2,5-diketo-1,3-dimethyl-imidazolidin-4-yl)acetic acid - Physico-chemical Properties
| Molecular Formula | C7H10N2O4 |
| Molar Mass | 186.17 |
| Storage Condition | Room Temprature |
| Sensitive | Irritant |
| MDL | MFCD06740197 |
2-(2,5-diketo-1,3-dimethyl-imidazolidin-4-yl)acetic acid - Risk and Safety
| Hazard Class | IRRITANT |
2-(2,5-diketo-1,3-dimethyl-imidazolidin-4-yl)acetic acid - Introduction
(1,3-Dimethyl-2,5-dioxoimidazolidin-4-yl)-acetic acid, also known as DMIDAA, is an organic compound. The following is an introduction to its nature, use, preparation and safety information:
Nature:
-Appearance: DMIDAA is a solid, usually in the form of white crystals or crystalline powder.
-Solubility: DMIDAA has a small solubility in water, but has good solubility in many organic solvents (such as alcohols, ethers and ketones).
-Stability: DMIDAA is a stable compound, which is not easy to decompose under conventional conditions.
Use:
-Pharmaceutical field: As an intermediate compound, DMIDAA can be used to synthesize a variety of biologically active compounds, such as drugs and pesticides.
-Organic synthesis: DMIDAA can be used as an acyl exchange reagent and a protecting group for amines in organic synthesis.
Preparation Method:
DMIDAA can be synthesized by the following steps:
1. Under appropriate reaction conditions, imodazespolu is sent to react with bromoacetic acid to generate imodazespolu 2-bromoacetic acid.
2. react 2-bromoacetic acid imodazerpolu with alkali to generate DMIDAA.
Safety Information:
Due to the special nature of chemicals, please follow the following safety measures:
-Use personal protective equipment such as gloves and safety glasses.
-Operate in a well-ventilated area and avoid inhalation or contact with skin.
-Follow the correct experimental operation and disposal methods to avoid harmful substances or dangerous reactions.
-For storage, store DMIDAA in a dry, cool place and separate from other chemicals.
Please note that DMIDAA is a chemical compound that is potentially dangerous. Observe relevant regulations and laboratory safety guidelines when using and handling. It is strongly recommended to operate under the guidance of an experienced professional.
Nature:
-Appearance: DMIDAA is a solid, usually in the form of white crystals or crystalline powder.
-Solubility: DMIDAA has a small solubility in water, but has good solubility in many organic solvents (such as alcohols, ethers and ketones).
-Stability: DMIDAA is a stable compound, which is not easy to decompose under conventional conditions.
Use:
-Pharmaceutical field: As an intermediate compound, DMIDAA can be used to synthesize a variety of biologically active compounds, such as drugs and pesticides.
-Organic synthesis: DMIDAA can be used as an acyl exchange reagent and a protecting group for amines in organic synthesis.
Preparation Method:
DMIDAA can be synthesized by the following steps:
1. Under appropriate reaction conditions, imodazespolu is sent to react with bromoacetic acid to generate imodazespolu 2-bromoacetic acid.
2. react 2-bromoacetic acid imodazerpolu with alkali to generate DMIDAA.
Safety Information:
Due to the special nature of chemicals, please follow the following safety measures:
-Use personal protective equipment such as gloves and safety glasses.
-Operate in a well-ventilated area and avoid inhalation or contact with skin.
-Follow the correct experimental operation and disposal methods to avoid harmful substances or dangerous reactions.
-For storage, store DMIDAA in a dry, cool place and separate from other chemicals.
Please note that DMIDAA is a chemical compound that is potentially dangerous. Observe relevant regulations and laboratory safety guidelines when using and handling. It is strongly recommended to operate under the guidance of an experienced professional.
Last Update：2024-04-09 21:04:16
